Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Raw Materials (2017 - 2025)

Nephros has reported Raw Materials over the past 9 years, most recently at $259000.0 for Q4 2025.

  • Quarterly results put Raw Materials at $259000.0 for Q4 2025, down 26.84% from a year ago — trailing twelve months through Dec 2025 was $259000.0 (down 26.84% YoY), and the annual figure for FY2025 was $259000.0, down 26.84%.
  • Raw Materials for Q4 2025 was $259000.0 at Nephros, up from $209000.0 in the prior quarter.
  • Over the last five years, Raw Materials for NEPH hit a ceiling of $1.1 million in Q1 2022 and a floor of $209000.0 in Q3 2025.
  • Median Raw Materials over the past 5 years was $406000.0 (2022), compared with a mean of $540350.0.
  • Biggest five-year swings in Raw Materials: surged 151.51% in 2021 and later tumbled 57.71% in 2023.
  • Nephros' Raw Materials stood at $807000.0 in 2021, then crashed by 47.71% to $422000.0 in 2022, then decreased by 22.75% to $326000.0 in 2023, then grew by 8.59% to $354000.0 in 2024, then decreased by 26.84% to $259000.0 in 2025.
  • The last three reported values for Raw Materials were $259000.0 (Q4 2025), $209000.0 (Q3 2025), and $258000.0 (Q2 2025) per Business Quant data.